Report Claims Clinical Trials Miss Many Populations
By Alan Mozes
HealthDay Reporter
Tuesday, April 1, 2008; 12:00 AM
TUESDAY, April 1 (HealthDay News) — A new analysis of the American clinical trial process suggests that the system for testing new drugs has routinely excluded or under-represented women, older people, minorities, disabled individuals and rural populations for decades.
“We’ve got a big problem,” said Daniel S. Goldberg, chief policy adviser for the report. “And it’s extremely urgent that we fix it.”
For more on clinical trials see http://www.nlm.nih.gov/medlineplus/clinicaltrials.html
For more on Health Disparities see http://www.nlm.nih.gov/medlineplus/healthdisparities.html